Intravenous (IV) Equipment Market to Reach USD 17.6 Billion by 2034

The Global Intravenous (IV) Equipment Market is witnessing robust growth as healthcare systems modernize delivery methods for fluids, nutrients, and drugs. According to Exactitude Consultancy, the market, valued at USD 10.8 billion in 2024, is projected to reach USD 17.6 billion by 2034, growing at a CAGR of 5.0 % during 2025-2034.
This expansion is supported by increasing chronic illness prevalence, demand for precise drug administration, and the rise of home-based infusion care.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/48311

Key Takeaways
• Market Size: USD 10.8 billion (2024) → USD 17.6 billion (2034)
• CAGR: 5.0 % (2025-2034)
• Top Products: IV Catheters, Infusion Pumps, and Administration Sets
• Leading End User: Hospitals dominate; home healthcare shows fastest growth
• Regional Leader: North America leads global adoption; Asia-Pacific grows fastest

Market Story
Intravenous (IV) therapy is essential for fluid management, medication delivery, and nutritional support in clinical and home settings. The market is evolving rapidly as technological innovations enhance safety, accuracy, and patient comfort.

Manufacturers are focusing on smart infusion pumps with digital controls, closed-system transfer devices (CSTDs) to prevent contamination, and needle-free connectors to minimize infection risks. The growing shift toward home healthcare for chronic conditions such as diabetes, cancer, and renal failure is also fueling demand for portable IV systems and remote monitoring solutions.

Additionally, global aging trends and the surge in hospital admissions post-pandemic have amplified the need for reliable IV therapy infrastructure in both developed and emerging markets.

Segmentation Overview
By Product Type
• IV Catheters
• Infusion Pumps (Volumetric, Syringe, Ambulatory)
• Administration Sets & Tubing
• Needleless Connectors
• Valves
• Fluid Bags and Solutions

By End User
• Hospitals
• Ambulatory Surgical Centers
• Homecare Settings
• Clinics and Specialty Centers

By Application
• Oncology
• Parenteral Nutrition
• Pain Management
• Antibiotic Administration
• Hydration Therapy
• Others

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Explore Full Report here: https://exactitudeconsultancy.com/reports/48311/intravenous-iv-market

Recent Developments
• Becton, Dickinson and Company (BD) launched a new generation of safety-engineered IV catheters designed to reduce blood exposure and improve clinician protection.
• Baxter International Inc. introduced smart infusion systems with cloud connectivity for real-time dosage monitoring and data analytics.
• ICU Medical, Inc. expanded its Plum 360 Infusion Platform globally, integrating advanced pump interoperability with EHR systems.
• Fresenius Kabi AG invested in manufacturing expansion for IV fluids and parenteral nutrition solutions in Asia and Europe.
• Smiths Medical launched its next-generation CSTD-compatible infusion sets, enhancing oncology and critical care safety.

Expert Quote
"The intravenous equipment market is transitioning toward intelligent, patient-centric systems.
Innovations in safety design, automation, and home infusion care are setting new standards in efficiency and reliability,"
said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=48311

Market Drivers
• Growing incidence of chronic diseases and hospital admissions
• Rapid adoption of smart, connected infusion systems
• Expansion of homecare and outpatient infusion services
• Rising emphasis on infection prevention and closed-system delivery
• Advancements in parenteral nutrition and oncology infusion therapies

Forecast and Outlook
By 2034, the IV equipment market will evolve toward fully digitized infusion ecosystems integrating AI-assisted flow control, wireless monitoring, and real-time dosing analytics. Hospitals will continue to account for the largest revenue share, but home infusion therapy is projected to grow at over 6.5 % CAGR, supported by telemedicine platforms and insurance coverage expansion.

Sustainability trends are also shaping the market, with manufacturers adopting biodegradable materials and recyclable polymer components to align with global green healthcare goals.

Regional Insights
• North America: Largest share due to strong hospital infrastructure and adoption of smart infusion technologies.
• Europe: Growth supported by increasing chronic disease management programs and hospital digitalization.
• Asia-Pacific: Fastest-growing region; large patient base, rapid healthcare investment, and domestic IV fluid production.
• Latin America: Expanding access to IV therapies through private hospitals and health insurance programs.
• Middle East & Africa: Steady growth driven by modernization of tertiary care facilities.

Conclusion
The Global Intravenous (IV) Equipment Market stands at the intersection of safety, technology, and accessibility.

As demand for advanced infusion therapy expands across hospitals and homecare environments, companies that prioritize automation, infection control, and connectivity will capture the next wave of growth in global healthcare delivery.

This report is also available in the following languages : Japanese (静脈内(IV)), Korean (정맥 주사(IV)), Chinese (静脉注射(IV)), French (Intraveineux (IV)), German (Intravenös (IV)), and Italian (Endovenoso (EV)), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/48311/intravenous-iv-market#request-a-sample

Related Reports

Graves Ophthalmopathy Market
https://exactitudeconsultancy.com/reports/72230/graves-ophthalmopathy-market

Intravenous Immunoglobulin Market
https://exactitudeconsultancy.com/reports/72414/intravenous-immunoglobulin-market

Superficial Vein Devices Market
https://exactitudeconsultancy.com/reports/72441/superficial-vein-devices-market

Bevacizumab Biosimilars Market
https://exactitudeconsultancy.com/reports/72673/bevacizumab-biosimilars-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.